MedPath

Clonazepam

CLONAZEPAM TABLETS, USP 1 mg CIV Rx only

Approved
Approval ID

ca79f244-7e6e-4612-af26-e6e5cefbd3a2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 14, 2023

Manufacturers
FDA

PD-Rx Pharmaceuticals, Inc.

DUNS: 156893695

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

clonazepam

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72789-314
Application NumberANDA077856
Product Classification
M
Marketing Category
C73584
G
Generic Name
clonazepam
Product Specifications
Route of AdministrationORAL
Effective DateJune 14, 2023
FDA Product Classification

INGREDIENTS (7)

LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CLONAZEPAMActive
Quantity: 1 mg in 1 1
Code: 5PE9FDE8GB
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Clonazepam - FDA Drug Approval Details